免疫組織化学の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

免疫組織化学の世界市場規模は2023年に32億4,000万米ドルと評価され、2024年の37億1,000万米ドルから2032年には110億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは14.6％で成長する見通しです。

世界の免疫組織化学市場は、慢性疾患の有病率の上昇と革新的な診断技術への大幅な投資により、大きな成長が見込まれています。創薬および薬剤開発における免疫組織化学の利用が増加し、この分野のプロバイダーにとってビジネスの可能性がさらに高まっています。また、コンパニオン診断の採用が進むことで、診断技術の進歩とともに新たなビジネスチャンスが生まれ、需要を喚起するものと予想されます。しかし、熟練した専門家の不足、高額な機器コスト、偽陽性のリスクなどの課題が市場の成長を阻害する可能性があります。とはいえ、早期診断の緊急の必要性と高度な診断オプションに対する意識の高まりは、免疫組織化学プロバイダーにとって好条件を生み出し、持続的な市場拡大への道を開くと予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

免疫組織化学市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 抗体
  • 一次抗体
  • 二次抗体
• 試薬
  • ブロッキング試薬
  • 発色基質
  • 定着剤
  • バッファー
  • 検出キット
• 装置
  • スライド染色システム
  • 組織マイクロアレイ
  • 自動IHC装置
  • 手動染色システム
• ソフトウェア
  • 画像解析ソフトウェア
  • ワークフロー管理ツール

免疫組織化学市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 診断
• 調査
• 法医学用途

免疫組織化学市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院および診断検査室
• 学術調査機関
• 製薬・バイオテクノロジー企業
• 契約調査機関（CRO）
• 法医学研究所

免疫組織化学市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• F. Hoffmann-La Roche Ltd-Switzerland
• Agilent Technologies, Inc.-USA
• Thermo Fisher Scientific Inc.-USA
• Merck KGaA-Germany
• Abcam PLC-UK
• Bio-Rad Laboratories, Inc.-USA
• PerkinElmer, Inc.-USA
• Cell Signaling Technology, Inc.-USA
• Bio SB-USA
• Danaher Corporation-USA
• Takara Bio Inc.-Japan
• Leica Biosystems（Danaher Corporation）-Germany
• Sakura Finetek USA, Inc.-USA
• Biocare Medical, LLC-USA
• Biogenex Laboratories-USA
• Miltenyi Biotec-Germany
• Enzo Life Sciences, Inc.-USA
• Diagnostic Biosystems-USA
• Bio-Techne Corporation-USA

結論と提言

Global Immunohistochemistry Market size was valued at USD 3.24 billion in 2023 and is poised to grow from USD 3.71 billion in 2024 to USD 11.05 billion by 2032, growing at a CAGR of 14.6% during the forecast period (2025-2032).

The global immunohistochemistry market is poised for significant growth, driven by the rising prevalence of chronic diseases and substantial investments in innovative diagnostic technologies. Increased utilization of immunohistochemistry in drug discovery and development further enhances business potential for providers in this sector. The growing adoption of companion diagnostics is anticipated to generate additional opportunities, alongside advancements in diagnostic technologies that will fuel demand. However, challenges such as a shortage of skilled professionals, high equipment costs, and the risk of false positives may impede market growth. Nevertheless, the urgent need for early diagnosis and heightened awareness of advanced diagnostic options are expected to create favorable conditions for immunohistochemistry providers, paving the way for sustained market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segments Analysis

Global Immunohistochemistry Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Antibodies, Reagents, Equipment and Software. Based on Application, the market is segmented into Diagnostics, Research and Forensic Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Market

The global immunohistochemistry market is significantly influenced by the rising incidence of chronic diseases, which underscores the essential role of immunohistochemistry in diagnostics. As the prevalence of these diseases continues to escalate globally, there is a corresponding increase in the demand for immunohistochemistry products and technologies. This growing need for accurate and efficient diagnostic tools to identify and monitor chronic conditions is poised to propel the market forward. Consequently, the increasing focus on improving diagnostic capabilities and patient outcomes through advanced immunohistochemistry solutions is anticipated to further drive market growth in the coming years.

Restraints in the Global Immunohistochemistry Market

The global immunohistochemistry market faces significant restraints due to the high costs associated with its products and technologies, which often involve sophisticated methodologies and considerable investment in research and development. These elevated expenses can hinder adoption among institutions with constrained budgets, ultimately impeding market growth. As a result, facilities with limited financial resources may be unable to integrate these advanced tools into their operations, restricting overall access to immunohistochemistry technologies. Consequently, the financial burden poses a challenge, preventing many healthcare and research establishments from fully benefiting from the advancements available in the immunohistochemistry sector.

Market Trends of the Global Immunohistochemistry Market

The Global Immunohistochemistry market is experiencing a transformative trend towards automation, driven by advancements in technology and the increasing demand for efficient diagnostic solutions. Automated immunohistochemistry systems are anticipated to enhance precision and reduce labor costs, presenting lucrative opportunities for market players. The integration of artificial intelligence into these systems is poised to revolutionize workflows, enabling faster and more accurate staining processes. As laboratories seek to optimize their operations amidst growing workloads, the adoption of automated solutions will not only streamline procedures but also elevate diagnostic capabilities, thereby positioning themselves favorably in an increasingly competitive healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Immunohistochemistry Market Size by Product & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Blocking Reagents
  • Chromogenic Substrates
  • Fixatives
  • Buffers
  • Detection Kits
• Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Automated IHC Instruments
  • Manual Staining Systems
• Software
  • Image Analysis Software
  • Workflow Management Tools

Global Immunohistochemistry Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Research
• Forensic Applications

Global Immunohistochemistry Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Forensic Laboratories

Global Immunohistochemistry Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam PLC - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (Danaher Corporation) - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenex Laboratories - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostic Biosystems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations